Lantern Pharma is proud to be featured by a multitude of media outlets. Our goal is to crush cancer, and by spreading word of our innovative technology we hope to open the door to more collaborations and partnerships than ever, to empower us to develop the right treatments for the right patients.
ThuMar 4th, 2021
A machine learning‐based gene signature of response to the novel alkylating agent LP‐184 distinguishes its potential tumor indications
By Umesh Kathad, Aditya Kulkarni, Joseph Ryan McDermott, Jordan Wegner, [...]
MonJan 25th, 2021
Technology Is Rapidly Changing Cancer Care
By Sai Balasubramanian, J.D., Forbes
ThuDec 10th, 2020
AI offers promise but faces barriers in drug development
By Joel Berg, MedCityNews
TueDec 8th, 2020
ThuNov 19th, 2020
Lantern Pharma AI milestone will cut cost, time and risk in developing new drug therapies
By Drug Discovery World
WedNov 18th, 2020
Dallas’ Lantern Pharma Hits Major Milestone on its AI Platform to Advance its Oncology Drug Research and Development
By Alex Edwards, Dallas Innovates